MSH2 and neoplasm: In summary, the intra-cecal implantation model described here, driven by Msh2 deficiency, had the characteristics of MMRd/MSI-H tumors and recapitulated the de novo tumors developed in VCMsh2 mice, with the potential for tumor growth monitoring by US or MRI.